LIFR and pancreatic adenocarcinoma: Kaplan-Meier analysis indicated that low LIFR was significantly associated with better DSS in ACC and PAAD, but high LIFR expression correlated with a better DSS for patients with BRCA, KIRC, KIRP, LUAD and SKCM-M (Figure 2D).